隔离的Kratom使用障碍用延长释放的布普伦诺芬收缩剂治疗
Benjamin B Swart1, Charles Reznikoff, Katie Steen
1From the Addiction Medicine Fellow, University of Minnesota, Minneapolis, MN (BBS); Associate Professor of Medicine, University of Minnesota, Internal Medicine and Addiction Medicine, Hennepin County Medical Center, Minneapolis, MN (CR); and Faculty Physician, Addictive Recovery Services, Veteran's Affairs Medical Center, Minneapolis, MN (KS).
一份病例报告详细介绍了一名36岁的男性,患有严重的kratom使用障碍,并成功地用布普伦诺芬治疗. 这突显了诊断和治疗 kratom 的挑战,强调了需要进一步研究.
科学领域:
- 成 药物 药物 药物 药物
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 克拉 (Mitragyna speciosa) 的使用越来越多,人们越来越担心它可能导致物质使用障碍.
- 有限的临床指南存在于诊断和管理Kratom使用障碍 (KUD).
更多相关视频
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Antidepressant Drugs: MAOIs and Other Agents
Drug Abuse and Addiction: Pharmacological Phenomena
Desensitization and Tachyphylaxis
Drug Dependence
